Collectively, these findings suggest that obesity-induced inflammation interfering with the cAMP-dominated signal transduction pathway through secondary IR and related inflammatory factors, stimulating CYP19 transcription and elevating the aromatase level. The gene discussed is CYP19A1; the disease is obesity due to melanocortin 4 receptor deficiency.